Vectura to stop developing asthma treatment after late-stage failure

The move will result in a negative impact of 40 million pounds ($51.3 million) on Vectura’s loss before tax in the current financial year.

Original source: https://health.economictimes.indiatimes.com/news/pharma/vectura-to-stop-developing-asthma-treatment-after-late-stage-failure/66809824?utm_source=RSS&utm_medium=ETRSS

Related Posts